Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma.
Ari J RosenbergNishant AgrawalAlexander T PearsonZhen GooiElizabeth BlairLouis PortugalJohn F CursioAditya JulooriJeffrey ChinKathryn RouseVictoria M VillaflorTanguy Y SeiwertEvgeny IzumchenkoMark W LingenDaniel J HarafEverett E VokesPublished in: British journal of cancer (2022)
This clinical trial was registered with ClinicalTrials.gov identifier: NCT01847326.